170842 ⎘
Detection or diagnosis of diseases; Neurological disorders; Dementia; Cognitive disorders Alzheimer
METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#602METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
#603ANTIBODIES TO TAU
#604Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides
#605Detecting Dementia and Alzheimer's Disease Associated Biomarkers Stabilized on Solid Support Materials
#606System and method for early detection of Alzheimers by detecting amyloid-beta using orbital angular momentum
#607Method of immunization for reducing toxic damaged caused by oligomeric form of the amyloid-beta protein with stable amyloid beta monomers and oligomers
#608Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#609OCULAR DETECTION OF AMYLOID PROTEINS
#610Methods of diagnosing and treating Alzheimer's disease with S-equol
#611ALZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF THE ERK1/ERK2 PHOSPHORYLATION RATIO-ALZHEIMER'S DISEASE-SPECIFIC MOLECULAR BIOMARKERS (ADSMB)
#612Method for producing a standard for detecting protein aggregates of a protein misfolding disease, standard and use thereof
#613Antibodies specific for hyperphosphorylated tau and methods of use
#614Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain
#615Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
#616ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#617Method of treating neurological conditions with oleandrin
#618Novel Method for the Detection of pGlu-Abeta Peptides
#619Compositions and methods for use in diagnosis of alzheimer's disease
#620Stable amyloid beta monomers and oligomers
#621Glucagon/GLP-1 receptor co-agonists
#622METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS
#623Functionalized eyewear device for detecting biomarker in tears
#624NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#625Detection of aggregated proteins associated with neurodegenerative disease using a photooxidation-induced amplification immunoassay
#626Diagnostic method for parkinson's disease and lewy body dementia
#627NOVEL BIOMARKERS FOR COGNITIVE IMPAIRMENT AND METHODS FOR DETECTING COGNITIVE IMPAIRMENT USING SUCH BIOMARKERS
#628BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER
#629Alzheimer's Disease
#630SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS
#631SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS
#632Antibodies against pathological forms of TDP-43 and uses thereof
#633Biomarkers of congnitive dysfunction
#634COMPLIMENT FACTOR I BIOASSAY
#635Method of providing disease-specific binding molecules and targets
#636BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER
#637METHOD FOR DETECTING AGGREGATE FORM OF AGGREGATE-FORMING POLYPEPTIDE
#638DIAGNOSTIC AUTOANTIBODY PROFILES FOR THE DETECTION AND DIAGNOSIS OF NEURODEGENERATIVE DISEASES
#639Monoclonal antibody against human tau protein
#640Biomarkers in nasal exhaled breath
#641IN VITRO COMPOSITIONS COMPRISING HUMAN SAMPLE AND AMYLOID TARGETING AGENT
#642METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
#643Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#644Antibody array for measuring a panel of amyloids
#645AGENTS USEFUL IN DIAGNOSTIC AND THERAPY OF BETA-AMYLOID AGGREGATION RELATED DISORDERS AND SCREENING METHODS
#646BIOMARKERS AND METHODS RELATING TO ALZHEIMER'S DISEASE
#647METHODS AND COMPOSITIONS FOR SELECTIVE DETECTION OF HOMOSYSTEINE
#648Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#649Selected reaction monitoring assays
#650Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#651Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#652METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA
#653Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#654Antibodies to Alpha Synuclein
#655ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID
#656Tau protease compositions and methods of use
#657N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
#658Methylated Peptides Derived from Tau Protein and their Antibodies for Diagnosis and Therapy of Alzheimer's Disease
#659USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER
#660Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease
#661Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#662Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#663Diagnosis methods, diagnostic agents, and therapeutic agents against alzheimer's disease and frontotemporal lobar degeneration, and screening methods for these agents
#664NEURAL SPECIFIC S100-BETA FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
#665AGENT CONTAINING IMIDAZOLE DIPEPTIDE
#666Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#667Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease
#668Systems, assays, and methods for determining risk factors for Alzheimer's disease
#669Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau
#670Small molecular probes, processes and use thereof
#671Ultra-highly sensitive electrochemical biosensor using beads and method for manufacturing the same
#672Mitochondrial preproteins as markers for Alzheimer's disease
#673METHOD FOR ENRICHING CNS-DERIVED EXOSOMES
#674GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#675Magnetic platform for direct and multiplex immune-based detection of trace amount of protein biomarkers
#676Immobilized protein system for rapid and enhanced multiplexed diagnostics
#677Diagnostic devices and methods of use
#678Amyloid beta detection by mass spectrometry
#679Label-Free Single and Multi-Photon Fluorescence Spectroscopy to Detect Brain Disorders and Diseases: Alzheimer, Parkinson, and Autism From Brain Tissue, Cells, Spinal Fluid, and Body Fluids
#680BIOMARKERS FOR PREDICTION, DIAGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASE
#681Modulation of synaptic maintenance
#682Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#683FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction
#684Accelerated evaluation of treatments to prevent clinical onset of neurodegenerative diseases
#685Traumatic Brain Injury and Neurodegenerative Biomarkers, Methods, and Systems
#686CONVERGENCE OF AGGREGATION RATE WITH VALIDATED PERIPHERAL DIAGNOSTIC FOR ALZHEIMER'S DISEASE
#687Anti-Aβ globulomer 4D10 antibodies
#688Antibodies specific to pyroglutamated Aβ
#689Device for detecting misfolded proteins and methods of use thereof
#690Antibodies specific for hyperphosphorylated tau and methods of use thereof
#691Methods and compositions comprising tau oligomers
#692BRAIN SPECIFIC EXOSOME BASED DIAGNOSTICS AND EXTRACORPOREAL THERAPIES
#693Attenuated total reflectance-based biosensor for conformation and secondary structure analysis
#694Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
#695Anti-Tau antibodies and methods of use
#696CELLULAR RESPONSE ASSAY FOR BIOFLUID BIOMARKER DISCOVERY AND DETECTION
#697Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
#698ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES
#699DIAGNOSIS OF A NEUROLOGICAL DISEASE
#700Method for the quantitative characterization of amyloid and/or aggregating peptides and/or proteins in a sample
#701Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#702Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
#703Biomarker and methods for early diagnosis of Alzheimer's disease
#704Method of diagnosis, prognostic or treatment of neurodegenerative disease
#705Measurement method for amyloid precursor protein cleavage peptides
#706SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#707Biomarkers for Dementia and Dementia Related Neurological Disorders
#708Modulation of synaptic maintenance
#709Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#710METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER'S DISEASE AND PREVENTION OR TREATMENT THEREOF
#711METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES
#712ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA-AMYLOID PROTEIN
#713Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#714Reducing memory loss in mammals suffering from alzheimer's disease
#715Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
#716Diagnosing and treating alzheimer's disease
#717Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use
#718Methods of diagnosing tau-protein-associated disease
#719Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
#720Method of providing disease-specific binding molecules and targets
#721MODIFICATION OF AMYLOID-BETA LOAD IN NON-BRAIN TISSUE
#722DYES FOR ANALYSIS OF PROTEIN AGGREGATION
#723HUMANIZED ANTIBODY
#724Tau imaging probe
#725Alzheimer's disease assay in a living patient
#726CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS
#727Biomarkers of Alzheimer's Disease Progression
#728Methods for treating spinocerebellar ataxia type I using RPA1
#729Cells expressing apolipoprotein E and uses thereof
#730Method of Identifying Biomarkers of Neurological Diseases and Diagnosis of Neurological Diseases
#731METHODS FOR SCREENING TO IDENTIFY THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND USE THEREOF
#732AB Modulating Peptides
#733TAU IMAGING PROBE
#734Method of treating neurological conditions with oleandrin
#735Biomarkers for memory loss
#736METHOD OF SCREENING FOR COMPOUNDS USEFUL IN THE TREATMENT OF ALZHEIMER DISEASE
#737Heterocyclic molecules for biomedical imaging and therapeutic applications
#738Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβaggregates
#739Diagnostic Test and Treatment/Prevention of Alzheimer's Disease
#740Pi-extended acedan derivatives, their application for two-photon microscopy imaging, and their application for two-photon microscopy imaging of amyloid-beta plaque in an alzheimer's disease animal model
#741Method for determination of amyloid peptides with anti-amyloid antibody
#742DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE
#743Antibody therapy for amyloid beta disease
#744Modulation of synaptic maintenance
#745Pharmaceutical composition for the treatment and/or prevention of disease involving abnormal accumulation of amyloid β protein
#746METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#747METHOD FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#748Methods for detecting Aβ oligomers
#749HUMANIZED ANTIBODY IGG1
#750Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
#751Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases
#752METHOD FOR DIAGNOSING NEURO-DEGENERATIVE DISEASE
#753MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#754Dickkopf (DKK) Proteins as Biomarkers for Cognitive Decline Associated with Alzheimer's Disease
#755Blood-based screen for detecting neurological diseases in primary care settings
#756Compositions and methods related to tauopathy
#757METHOD FOR DETERMINING FREE COPPER
#758Diagnostic testing in dementia and methods related thereto
#759Biosensor using cell that expresses chemosensory receptor that can detect sugar, and alzheimer's disease diagnostic apparatus comprising same
#760METHODS FOR DIAGNOSING AND ASSESSING NEUROLOGICAL DISEASES
#761Biomarker for psychiatric and neurological disorders
#762Gamma-Secretase Substrates and Methods of Use
#763Computer systems for treating diseases
#764MATERIALS AND METHODS RELATING TO ALZHEIMER'S DISEASE
#765Method of In Vitro Diagnosis of a Neurological Disorder
#766Diagnostic kit for diagnosis of abnormal protein aggregation- or misfolding-related diseases using dissociation of protein aggregates
#767Method for diagnosis of dementias and neuroinflammatory diseases based on an increased level of procalcitonin in cerebrospinal fluid
#768METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#769System and method for early detection of alzheimers by detecting amyloid-beta using orbital angular momentum
#770BIOMARKERS
#771Detection of misfolded amyloid beta protein
#772METHODS FOR ANALYZING BLOOD TO DETECT DISEASES ASSOCIATED WITH ABNORMAL PROTEIN AGGREGATION
#773Uses of antibodies directed against amyloid-β
#774FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving Tau dysfunction
#775METHOD AND SYSTEM TO DETECT, DIAGNOSE, AND MONITOR THE PROGRESSION OF ALZHEIMER'S DISEASE
#776Modulators of alpha-synuclein toxicity
#777NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#778Tau immunotherapy
#779Amyloidosis-inhibiting polypeptides and their use
#780Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
#781NEW DUAL BIOMARKER OF NEURODEGENERATION AND OF NEUROREGENERATION
#782Aβ protofibril binding antibodies
#783Polynucleotides encoding anti-amyloid beta monoclonal antibodies
#784IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#785Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
#786Glucagon/GLP-1 receptor co-agonists
#787Diagnosis of Alzheimer Disease, Cognitive Decline and Dementia
#788Modulation of synaptic maintenance
#789Modulation of synaptic maintenance
#790Modulation of synaptic maintenance
#791Amyloid beta expression constructs and uses therefor
#792METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE
#793Method for diagnosing neurodegenerative diseases
#794Antibodies that bind amyloid oligomers
#795Method for detection of aggregates in biological samples
#796Diagnostic method based on large scale identification of post-translational modification of proteins
#797MEANS AND METHOD FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#798Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies
#799Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer's and vascular dementia
#800Method and kit for determination of free copper in serum
#801Spectroscopic method for Alzheimer's disease diagnosis
#802Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#803CD44 splice variants in neurodegenerative diseases
#804Antibodies, kit and method for detecting amyloid beta oligomers
#805Modular chemiresistive sensor
#806QUANTIFICATION OF TAU IN BIOLOGICAL SAMPLES BY IMMUNOAFFINITY ENRICHMENT AND MASS SPECTROMETRY
#807Method for aiding diagnosis of Alzheimer's disease
#808Methods and compositions for treating alzheimer's disease
#809NEUROFURANS-INDICES OF OXIDANT STRESS
#810GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#811METHODS AND COMPOSITIONS FOR DIAGNOSIS, STRATIFICATION, AND MONITORING OF ALZHEIMER'S DISEASE AND OTHER NEUROLOGICAL DISORDERS IN BODY FLUIDS
#812HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES
#813THE USE OF GENE EXPRESSION PROFILING AS A BIOMARKER FOR ASSESSING THE EFFICACY OF HDAC INHIBITOR TREATMENT IN NEURODEGENERATIVE CONDITIONS
#814COVALENTLY BOUND METABOLITES AS BIOMARKERS
#815Diagnostic assay for Alzheimer's disease
#816ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#817Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
#818BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE
#819Antibodies to tau
#820DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#821CELLULAR AND ANIMAL MODELS FOR SCREENING THERAPEUTIC AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#822Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#823SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS
#824Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#825METHOD FOR DETERMINING DISEASE SEVERITY IN TAUOPATHY-RELATED NEURODEGENERATIVE DISORDERS
#826METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
#827NEURAL SPECIFIC S100B FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
#828MULTIPLEX AVIDITY PROFILING OF PROTEIN AGGREGATES
#829BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER
#830Ocular detection of amyloid proteins
#831Polymers containing multivalent amyloid-beta-binding D-peptides and their use
#832Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders
#833Conformational-specific antibodies against A[β] oligomers
#834BIOMARKER FOR EARLY NEURODEGENERATION DETECTION
#835METHOD AND SYSTEM TO DETECT AND DIAGNOSE ALZHEIMER'S DISEASE
#836METHOD AND KIT FOR DETECTION OF ANTI-BETA AMYLOID ANTIBODIES
#837Curcumin derivatives for amyloid-β plaque imaging
#838Glycopeptide and uses thereof
#839Accelerated evaluation of treatments to prevent clinical onset of alzheimer's disease
#840QUICK TEST FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#841METHODS OF TREATING AMYLOIDOSES WITH VITAMIN B12 AND DIAGNOSTIC TEST FOR DETECTING THE PRESENCE OF AMYLOID-BETA PEPTIDES
#842Biochemical markers for neurodegenerative conditions
#843CELLULAR MARKERS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE AND FOR ALZHEIMER'S DISEASE PROGRESSION
#844Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
#845Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#846METHOD FOR IDENTIFYING DISEASE ASSOCIATED WITH ABUNDANCE OF TDP-43 IN CELL
#847Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#848STANDARD FOR QUANTIFYING PATHOGENIC AGGREGATES FROM PROTEINS PRODUCED NATURALLY IN THE BODY
#849METHOD AND SYSTEM FOR DIAGNOSING ALZHEIMER'S DISEASE
#850METHOD FOR SELECTIVELY QUANTIFYING A-BETA AGGREGATES
#851Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy
#852METHODS OF DIAGNOSING TAU-ASSOCIATED NEURODEGENERATIVE DISEASES
#853METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER'S DISEASE AND PREVENTION OR TREATMENT THEREOF
#854Methods of treating brain injury
#855HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY
#856METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE
#857Method for diagnosing alzheimer's disease
#858Therapeutic approach for polyglutamine degeneration
#859MARKERS FOR ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT AND METHODS OF USING THE SAME
#860APOE IMMUNOTHERAPY
#861Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities
#862FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
#863Biomarkers for prediction, diagnosis, and monitoring of Alzheimer's disease
#864Biomarkers for prediction, diagnosis, and monitoring of parkinson's disease
#865Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
#866Process for detection of alzheimer's disease from a serum sample
#867USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAIN
#868Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
#869Phosphospecific antibodies recognising tau
#870Tau protease compositions and methods of use
#871In vivo cellular screening methods and compositions for modeling and treating nervous system dysfunction
#872Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
#873RNA splicing alterations and U1 small nuclear ribonucleoproteins in neurodegenerative diseases
#874Diagnostic antibody assay
#875Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication
#876Method for diagnosing alzheimer's disease (AD)
#877Glycopeptide and uses thereof
#878Glucagon/GLP-1 receptor co-agonists
#879Monoclonal antibody
#880Methods of treating alzheimer's disease by administration of protective protein/cathepsin A
#881Discordant helix stabilization for prevention of amyloid formation
#882Methods of reducing levels of tau
#883Compositions and methods related to tauopathy
#884FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#885Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domain
#886Agents that reduce neuronal overexcitation
#887Anti-N3pGlu amyloid beta peptide antibodies and uses thereof
#888Methods and compositions for monitoring phagocytic activity
#889Aβ-remover, Aβ-removing apparatus, and Aβ removal method
#890Diagnosis and treatment of Alzheimer's disease
#891Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)
#892Monoclonal antibodies against GMF-B antigens, and uses therefor
#893Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#8941,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
#895Antibody, kit and method for determining amyloid peptides
#896Alzheimer's disease assay in a living patient
#897Alzheimer's disease assay in a living patient
#898Anitbodies specific for the protofibril form of beta-amyloid protein
#899Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
#900Biological complex specific for Alzheimer's disease detection in vitro and use thereof